OTC Medications for Cough, Runny Nose, and Congestion in Adults
For adults with cough, runny nose, and nasal congestion from upper respiratory infection, use oral or intranasal decongestants (pseudoephedrine or oxymetazoline) for congestion relief up to 3 days, but understand that evidence for cough suppressants like dextromethorphan is weak and inconsistent. 1, 2
Nasal Congestion - First Priority
Decongestants are your most effective option for nasal congestion:
- Oral decongestants (pseudoephedrine) reduce nasal congestion effectively 1
- Topical nasal decongestants (oxymetazoline, xylometazoline) work rapidly and can be used safely for up to 7-10 days without evidence of rebound congestion at recommended doses 3
- The traditional "3-day limit" appears overly conservative based on recent evidence
- Oxymetazoline shows no rebound congestion for up to 4 weeks in well-designed studies 3
Important caveats: Avoid oral decongestants if the patient has hypertension, insomnia, or anxiety. Side effects include insomnia, irritability, palpitations, and elevated blood pressure 1.
Runny Nose (Rhinorrhea)
For rhinorrhea specifically:
- Intranasal ipratropium (anticholinergic) is the most targeted treatment - it reduces rhinorrhea but not other symptoms 1
- First-generation antihistamines may help but cause sedation and anticholinergic effects
- Second-generation antihistamines (cetirizine, loratadine, fexofenadine) are less effective for runny nose from viral URI compared to allergic rhinitis 1
Cough - The Evidence is Disappointing
The reality about cough suppressants is sobering:
- Dextromethorphan may provide modest benefit in adults, but evidence is inconsistent 2, 4
- Codeine has NOT been shown to effectively treat cough from common cold 5, 2
- A 2014 Cochrane review found no good evidence for or against OTC cough medicines - studies showed conflicting results with questionable clinical relevance 4
The guideline evidence supports codeine and dextromethorphan only for chronic bronchitis, not for URI-related cough 5. For acute viral URI cough, there is genuinely no proven effective OTC option 6, 4.
Combination Products
Antihistamine-decongestant combinations show some benefit in adults for overall symptom relief, though results are mixed 1, 2. The benefit must be weighed against increased side effects, particularly sedation with first-generation antihistamines 1.
What NOT to Use
- Expectorants (guaifenesin): Conflicting evidence, with most studies showing no benefit 5, 6
- Second-generation antihistamines alone: Ineffective for viral URI symptoms 2
- Antibiotics: No benefit for symptom relief or illness duration 2
Practical Algorithm
- Congestion dominant? → Oral pseudoephedrine or intranasal oxymetazoline (check for contraindications first)
- Rhinorrhea dominant? → Intranasal ipratropium (prescription required) or first-generation antihistamine if sedation acceptable
- Cough dominant? → Set realistic expectations - no proven effective OTC option. Consider dextromethorphan for possible modest benefit, but evidence is weak
- Multiple symptoms? → Antihistamine-decongestant combination may provide modest overall relief
Critical Pitfall
The most important message: The evidence for most OTC cough and cold medications is surprisingly weak 6, 4. Multiple Cochrane reviews conclude there is "no good evidence for or against effectiveness" of these widely used products. Counsel patients about realistic expectations - symptom relief may be modest at best, and many products have no proven benefit beyond placebo.